Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    20089952 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Evaluating of the Effect of Fingolimod With Fish Oil on Relapsing-Remitting Multiple Sclerosis Patients
Condition: Multiple Sclerosis
Interventions: Drug: Fingolimod;   Dietary Supplement: Fish Oil;   Drug: Placebo (for Fish Oil)
2 Completed
Has Results
Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis
Condition: Relapsing-remitting Multiple Sclerosis
Interventions: Drug: Fingolimod 1.25 mg;   Drug: Fingolimod 0.5 mg;   Drug: Placebo

Indicates status has not been verified in more than two years